Crossmark

Liver dysfunction in anti-melanoma differentiation-associated gene 5 antibody-positive patients with dermatomyositis

Crossref DOI link: https://doi.org/10.1007/s00296-019-04255-2

Published Online: 2019-02-21

Published Print: 2019-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nagashima, Takao https://orcid.org/0000-0003-0620-6774
Kamata, Yasuyuki https://orcid.org/0000-0002-8174-3038
Iwamoto, Masahiro https://orcid.org/0000-0002-3616-1303
Okazaki, Hitoaki https://orcid.org/0000-0002-0277-5673
Fukushima, Noriyoshi https://orcid.org/0000-0002-4522-9007
Minota, Seiji https://orcid.org/0000-0003-4084-6804
License Information

Text and Data Mining valid from 2019-02-21
More Information

Article History

Received: 14 January 2019

Accepted: 14 February 2019

First Online: 21 February 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: This study complied with the guidelines of the Declaration of Helsinki and was approved by Jichi Medical University’s Institutional Review Board (No. 17–062, May 29, 2017). The requirement for the need to obtain written informed consent from the patients was waived in accordance with the relevant Japanese regulations.